Raul R. Rodriguez
CIK: 0001190279
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (9.1%)
Position reduction
Option Exercises (M)4 (18.2%)
Derivative conversions
Awards (A)8 (36.4%)
Compensation grants
Other (G, F, J, C, D, …)8 (36.4%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RIGL
RIGEL PHARMACEUTICALS INC
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History
About RODRIGUEZ RAUL R
RODRIGUEZ RAUL R (SEC CIK 0001190279) files insider reports with the SEC as CEO, President of RIGEL PHARMACEUTICALS INC (RIGL).
Signal8 holds 13 ownership filings by RODRIGUEZ RAUL R, all Form 4s, filed between Sep 4, 2024 and Sep 3, 2026. Those filings report 22 transactions, from Aug 30, 2024 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on RODRIGUEZ RAUL R's filings is in SOUTH SAN FRANCISCO, CA.
Other insiders filing for RIGEL PHARMACEUTICALS INC (RIGL)
- Schorno Dean L, EVP & Chief Financial Officer
- Santos David A, EVP, Chief Commercial Officer
- Furey Raymond J., EVP, GC, CCO & Corp Sec
- HANNAH ALISON L., EVP, Chief Medical Officer
- Ali-Jackson Kamil, Director
- Rojkjaer Lisa, EVP, Chief Medical Officer